Top 5 Countries with the Best Patient Access to New Oncology Medication
Access to new cancer medications varies greatly by country.
From 2010 to 2014, there were 49 new cancer medications launched. Researchers found that 25 of these medications were available for use in 20 or more countries and 49 were available in 10 or less countries.
Patient access to these medications vary greatly between developed and pharmerging countries, according to the IMS Institute Global Oncology Trend Report.
The report found that patients in some countries, like Vietnam, only had access to 1 of the new medications, while patients in other countries had greater access.
The 5 countries with the most patient access to new oncology medications launched between 2010 and 2014 were:
- United States
Overall, US patients had the best access to the drugs launched within this time period but only had access to 41 of them.
This country’s patients only had access to 38 of the 49 drugs launched within the 4-year period.
- United Kingdom
UK patients had access to 37 drugs, only 1 less than German patients.
Italy had access to 31 of the medications launched during this time.
- France and Canada
Both of these countries only had access to 28 of the 49 medications.